EPM
BLUE

Equitec Proprietary Markets’s bluebird bio BLUE Stock Holding History

Equitec Proprietary Markets’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110,714
Closed -$540K – 71
2025
Q1 		$540K Buy
+110,714
New +$666K 0.38% 24

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Equitec Proprietary Markets's BLUE Position: Q2 2025 in Review

Equitec Proprietary Markets sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 110,714 shares — an estimated $540K sold.

Equitec Proprietary Markets first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $540K in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Equitec Proprietary Markets reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Equitec Proprietary Markets sold 110,714 bluebird bio shares in Q2 2025, an estimated $540K.
  • Equitec Proprietary Markets first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
  • Equitec Proprietary Markets's bluebird bio position peaked at $540K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Equitec Proprietary Markets's 13F filing for Q2 2025, filed 6 Aug 2025.